Irina Ganeeva

457 total citations
16 papers, 344 citations indexed

About

Irina Ganeeva is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Irina Ganeeva has authored 16 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Irina Ganeeva's work include CAR-T cell therapy research (10 papers), Virus-based gene therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Irina Ganeeva is often cited by papers focused on CAR-T cell therapy research (10 papers), Virus-based gene therapy research (5 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Irina Ganeeva collaborates with scholars based in Russia, Sweden and Kazakhstan. Irina Ganeeva's co-authors include Emil Bulatov, Ekaterina Zmievskaya, Albert A. Rizvanov, Aygul Valiullina, Alexey Petukhov, Regina Miftakhova, Aleksei Titov, Anna A. Kudriaeva, Yaroslav Kaminskiy and M. N Zhuravleva and has published in prestigious journals such as Blood, Frontiers in Immunology and Journal of Molecular Liquids.

In The Last Decade

Irina Ganeeva

15 papers receiving 336 citations

Peers

Irina Ganeeva
Irina Ganeeva
Citations per year, relative to Irina Ganeeva Irina Ganeeva (= 1×) peers Aygul Valiullina

Countries citing papers authored by Irina Ganeeva

Since Specialization
Citations

This map shows the geographic impact of Irina Ganeeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irina Ganeeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irina Ganeeva more than expected).

Fields of papers citing papers by Irina Ganeeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irina Ganeeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irina Ganeeva. The network helps show where Irina Ganeeva may publish in the future.

Co-authorship network of co-authors of Irina Ganeeva

This figure shows the co-authorship network connecting the top 25 collaborators of Irina Ganeeva. A scholar is included among the top collaborators of Irina Ganeeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irina Ganeeva. Irina Ganeeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ganeeva, Irina, et al.. (2025). Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid Tumors. Biomedicines. 13(9). 2314–2314.
2.
Ganeeva, Irina, et al.. (2025). The importance of TP53 status in cancer therapy: The example of chronic lymphocytic leukemia.. PubMed. 14(3). 179–198. 1 indexed citations
3.
Zmievskaya, Ekaterina, Irina Ganeeva, Yuriy Davidyuk, et al.. (2024). Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies. Antibodies. 13(1). 10–10. 20 indexed citations
4.
Zmievskaya, Ekaterina, Irina Ganeeva, М. П. Кутырева, et al.. (2024). Artificial Extracellular Vesicles Generated from T Cells Using Different Induction Techniques. Biomedicines. 12(4). 919–919. 6 indexed citations
5.
Zmievskaya, Ekaterina, et al.. (2024). Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation. Journal of Biomedical Research. 38(6). 531–531. 3 indexed citations
6.
Kaminskiy, Yaroslav, et al.. (2024). Asymmetric T-cell division: insights from cutting-edge experimental techniques and implications for immunotherapy. Frontiers in Immunology. 15. 1301378–1301378. 3 indexed citations
7.
Ganeeva, Irina, et al.. (2024). Cell-Based Therapy and Genome Editing as Emerging Therapeutic Approaches to Treat Rheumatoid Arthritis. Cells. 13(15). 1282–1282. 5 indexed citations
8.
Ganeeva, Irina, et al.. (2024). Gut Microbiota Modulation: A Novel Strategy for Rheumatoid Arthritis Therapy. Biomolecules. 14(12). 1653–1653. 9 indexed citations
9.
Zmievskaya, Ekaterina, Irina Ganeeva, M. N Zhuravleva, et al.. (2023). Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines. Biomedicines. 11(2). 626–626. 29 indexed citations
10.
Titov, Aleksei, Yaroslav Kaminskiy, Irina Ganeeva, et al.. (2022). Knowns and Unknowns about CAR-T Cell Dysfunction. Cancers. 14(4). 1078–1078. 38 indexed citations
11.
Yakimova, Luidmila S., Olga A. Mostovaya, Gennady Evtugyn, et al.. (2022). Encapsulation of the quercetin with interpolyelectrolyte complex based on pillar[5]arenes. Journal of Molecular Liquids. 368. 120807–120807. 10 indexed citations
12.
Ganeeva, Irina, Ekaterina Zmievskaya, Aygul Valiullina, et al.. (2022). Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies. Bioengineering. 9(12). 808–808. 32 indexed citations
13.
Zmievskaya, Ekaterina, et al.. (2021). Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies. Frontiers in Immunology. 12. 707734–707734. 36 indexed citations
14.
Titov, Aleksei, Ekaterina Zmievskaya, Irina Ganeeva, et al.. (2021). Adoptive Immunotherapy beyond CAR T-Cells. Cancers. 13(4). 743–743. 73 indexed citations
15.
Zmievskaya, Ekaterina, Aygul Valiullina, Irina Ganeeva, et al.. (2021). Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections. Biomedicines. 9(1). 59–59. 78 indexed citations
16.
Zmievskaya, Ekaterina, M. N Zhuravleva, Irina Ganeeva, et al.. (2020). The Effect of Macrophage Polarization on Cytokine Release in CAR-T Antitumor Response. Blood. 136(Supplement 1). 22–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026